Navigation Links
'Hibernation-on-demand' drug significantly improves survival after extreme blood loss
Date:7/1/2008

SEATTLE For the first time, researchers have demonstrated that the administration of minute amounts of inhaled or intravenous hydrogen sulfide, or H2S the molecule that gives rotten eggs their sulfurous stench significantly improves survival from extreme blood loss in rats.

Cell biologist Mark B. Roth, Ph.D., and colleagues in the Basic Sciences Division of Fred Hutchinson Cancer Research Center, in collaboration with surgeon Robert K. Winn, Ph.D., and colleagues at UW Medicine's Harborview Medical Center, report their findings online ahead of print in The Journal of Trauma Injury, Infection, and Critical Care. The article is slated for the July print issue, which comes out on July 10.

The researchers successfully used H2S to induce a state of reversible metabolic hibernation as a way to reduce death from insufficient blood supply to organs and tissues in a rat model of lethal hemorrhage. (Federal regulations mandate the use of such animal models in preclinical research to test the safety and effectiveness of various procedures and treatments before they can be tested in humans.)

They found that 75 percent of rats (18 of 24) given inhaled hydrogen sulfide and 67 percent of rats (eight of 12) given intravenous hydrogen sulfide survived at least two weeks the duration of the monitoring period after losing more than half of their blood for an extended period. In contrast, long-term survival rates for the untreated rats in the two control groups were 23 percent (three of 13) and 14 percent (one of seven), respectively.

"Our goal is to develop life-saving treatment for critically ill people suffering from acute, sustained blood loss, such as in a car accident or on the battlefield," said senior author Roth. "These findings have obvious implications for the military, but they also have tremendous implications for the civilian population."

The U.S. Defense Advanced Research Projects Agency and the U.S. Defense Servic
'/>"/>

Contact: Kristen Lidke Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
2. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
3. Study shows adverse drug events reported to the FDA have significantly increased
4. Rehabilitation significantly underused after heart attack and bypass surgery
5. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
6. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
7. New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work
8. World Bank Group Report on Malaria in Africa Highlights Progress Towards Goal of Significantly Reducing Malaria Deaths
9. Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
10. Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
11. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...M. Marlon, MD was elected to the Stemedica Cell Te...f Directors at the Company’s November 20th B...ecember 1, 2009 -- Anthony M. Marlon, MD was elect...quo;Stemedica”) Board of Directors at the Co.... Howe, PhD, Executive Chairman for Stemedica made...
(Date:12/1/2009)...., Dec. 1 To date, hospitals have ...rse them for the $20 cost of the disposable sensor...ery. ,, Anesthesiologists have not told hospita...op dementia from routine anesthesia over-medicatio...id over-medication, message from their leaders bec...
(Date:12/1/2009)... Cell Therapeutics, Inc....ation at the 21st Annual Piper Jaffray Health Care...astern Time will be webcast live at www.cellthera...lace in Holmes 1 at the New York Palace Hotel, and...ntation. , , Piper Jaffray H...
(Date:12/1/2009)... at the annual meeting of the Radiological Society...ghly accurate means of identifying placenta accret... common condition that is the leading cause of dea..., "Due to the increase in cesarean sections and ... wall, coupled with women giving birth later in li...
(Date:12/1/2009)..., controlled clinical trial presented today at the...th America (RSNA) reveal that one in five patients...y blood to the legs and other parts of the body al...ease. , Peripheral arterial disease (PAD) occur...nd other substances, builds up in the arteries, li...
Breaking Medicine News(10 mins):Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2
...e Mesothelioma Applied Research, Foundation (Meso... House, Energy and Commerce Committee on the "Bruc...t"(HR 3339), today, Thursday, February 28, 2008. T...oma and partner with the Meso Foundation in dev...
...in and European Commission Director General for En...russels an agreement which establishes the allocat...tribution to the implementation of the GMES Space ...be submitted for subscription by ESAs Member State...
... for one million children, WASHINGTON, Feb. 28 T... the recognized leader in children,s oral health, ...ead Start (OHS) to help combat,children,s tooth de...or one million children enrolled annually,in OHS p...
...ation Program This Spring, LOVELAND, Ohio, Feb. 2...a non-profit 501(c)(3) organization that promotes,...e evaluations of,population health management prog...rrent Board members Thomas Wilson,Ph.D., DrPH (Cha...
...r,groups said today that they will continue their ...tem cells held by the Wisconsin Alumni,Research Fo...tent Office,allowing three amended claims in one o...later final decision,by the examiner supporting th...
...e distinctive ability of mothers to identify the c...e, where it is critical to the survival of these o...ctive ability of mothers to recognize and respond ...a very limited understanding of how the maternal b...
Other Medicine News:Health News:Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation 2Health News:Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation 3Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 2Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 3Health News:AAPD Announces Partnership With Head Start to Address Childhood Epidemic 2Health News:AAPD Announces Partnership With Head Start to Address Childhood Epidemic 3Health News:Population Health Impact Institute Announces New Board Members 2Health News:Consumer Groups Will Continue to Press Stem Cell Patent Challenge 2Health News:Maternal love: How a mother's brain responds to her infant 2
(Date:11/30/2009)..., , BOTHELL, Wash., Nov. 30 /PRNewswire-F... announced today that on November 25, 2009, the NY...that it had accepted the Company,s plan to comply ...nder Section 1003(a)(iv) of the Exchange Company G...that the Company sustained losses which were so su...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 ...arch report is available in its catalogue: ,, ...igence Report ,, http://www.reportlinker.com/...et-Intelligence-Report.html ,, Cardiovascular...eaths globally. Sudden cardiac arrest survivors ar...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 ...arch report is available in its catalogue: ,, ...009 - 2014) ,, http://www.reportlinker.com/p0...vice.html ,, Report Description ,, Medical...lthcare sector with an estimated size of $250 bill...
Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5568 1Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5568 2Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5568 3Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5568 4Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5568 5FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 1FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 2Childhood ADHD Linked to Criminal Behavior in Adults 59767 1Childhood ADHD Linked to Criminal Behavior in Adults 59767 2
...a., Dec. 21 Romark Laboratories, L.C., a,privatel... closing of an,$18 million institutional financing...s financing will enable Romark to advance,developm...eatment of,hepatitis C, and advance its next-gener... of hepatitis B and C and other viral diseases. Ro...
...re license revenue increases more than 100% in thi...a, the global,leader in scalable behavior change i...rtnerships and continued to experience rapid growt...y also introduced,enhancements to its HealthMedia ...ship and innovation., HealthMedia,s health care l...
Other Medicine Technology:HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 2HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 3
AIA-600 II
...c Antigen Rapid Test Strip and Device (Whole Blood... device formats for the semi-quantitative detectio...e available with 4 ng/mL or 3 ng/mL cut-off values...y can be performed using serum, plasma or whole bl...
... Contrast Sensitivity. The Optec 6500 controls bot...or accurate and repeatable testing results. Day/Ni...nance Comply with International Standards and all ...ntrolled and Continually Calibrated. The Optec 650...
Functional Acuity Contrast Test
Medicine Products: